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Open access under CC BYMethodological limitations have hampered the use of heavy water (2H2O), a convenient, universal biosyn-
thetic label, for measuring protein synthesis. Analyses of 2H-labeled amino acids are sensitive to contam-
ination; labeling of peptides has been measured for a few serum proteins, but this approach awaits full
validation. Here we describe a method for quantifying protein synthesis by peptide mass spectrometry
(MS) after 2H2O labeling, as applied to various proteins of the major histocompatibility complex (MHC).
Human and murine antigen-presenting cells were cultured in medium containing 5% 2H2O; class I and
class II MHC proteins were immunoprecipitated, bands were excised, and Ala-/Gly-rich, allele-speciﬁc
tryptic peptides were identiﬁed by liquid chromatography–tandemmass spectrometry (LC–MS/MS). Mass
isotopomer distributions were quantiﬁed precisely by LC–MS and shifted markedly on 2H2O labeling.
Experimental data agreed closely with models obtained by mass isotopomer distribution analysis (MIDA)
and were consistent with contributions from Ala, Gly, and other amino acids to labeling. Estimates of frac-
tional protein synthesis from peptides of the same protein were precise and internally consistent. The
method was capable of discriminating between MHC isotypes and alleles, applicable to primary cells,
and readily extendable to other proteins. It simpliﬁes measurements of protein synthesis, enabling novel
applications in physiology, in genotype/phenotype interactions, and potentially in kinetic proteomics.
 2010 Elsevier Inc.Open access under CC BY-NC-ND license.Protein synthesis has classically beenmeasured by incorporation in animals, has been used [1–4]. This approach is safe and the ratio
of radiolabeled amino acids, but this approach is difﬁcult to use in
animals and is too hazardous for routine human use. Moreover,
turnover measurements by radiolabeling are sensitive to variable
protein losses during sample preparation. Alternatively, labeling
with 2H- or 13C-substituted essential amino acids, in cell culture
(stable isotope labeling of amino acids in cell culture [SILAC])2 orch).
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-NC-ND license.of labeled to unlabeled species is quantiﬁed, so variable recovery
has little impact on results. However, calculation of fractional protein
synthesis requires an understanding of precursor/product relation-
ships, which can be confounded by complexity in intracellular amino-
acyl transfer RNA (tRNA) pools and by recycling of unlabeled amino
acids. In vivo, complete replacement of endogenous amino acids takes
several generations [2], and long-term experiments are expensive,
due to the requirement of modiﬁed diets or infusion of the labeled
precursor. The accuracy of the kinetic information obtained remains
unclear.
An alternative approach for the analysis of long-lived proteins
(t1/2P hours) employs stable isotope labeling of nonessential ami-
no acids with heavy water (SINEW) [5–7]. This is an extension of
well-established methods for measuring the synthesis of lipids
and DNA [8,9]. Body water is routinely enriched to 5% heavy water
(2H2O [deuterated water, D2O]) in rodents, and to 1–2% in humans,
without perturbing normal physiology [8]. After 2H2O intake, 2H
atoms rapidly equilibrate across body water pools. CAH bonds of
free glycine and alanine [5–7,10], and of several other nonessential
amino acids (NEAAs) [11], then approach isotopic equilibrium
with body water. Thereafter, protein biosynthesis becomes the
2 Protein synthesis using 2H2O labeling and peptide MS / A. De Riva et al. / Anal. Biochem. 403 (2010) 1–12rate-limiting step for 2H incorporation (Fig. 1A). Body water turns
over slowly [12], and a ﬁxed enrichment is maintained indeﬁnitely
by regular oral 2H2O intake [8]. This enables extended labeling pro-
tocols for quantiﬁcation of slow protein turnover rates. The analyt-
ical approach used in most studies to quantify label incorporation
involves total hydrolysis of proteins of interest to single amino
acids and quantiﬁcation of 2H incorporation into NEAA (most often
Ala) by gas chromatography–mass spectrometry (GC–MS) [5–
7,13–15]. This approach is precise and sensitive, but it can easily
be confounded by contamination with extraneous proteins or free
amino acids; in practice, applications have been limited to rela-
tively abundant, easily puriﬁed proteins. Analysis of 2H-labeled
tryptic protein fragments [16,17] is less easily confounded, but
studies have been limited to rodent serum albumin and contami-
nants of albumin preparations; methods for estimating fractionalE F
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Fig. 1. Application of SINEW with peptide LC–MS to cultured antigen presenting cell lin
Flow chart of experimental approach. (C) 2H2O labeling does not perturb cell growth. Gr
without 4.5% 2H2O. Exponential curve ﬁts and doubling times (t2) are shown. (D) Consta
excess over natural abundance) was veriﬁed by IRMS analysis of medium sampled at
molecules were immunoprecipitated from host cell lines (Priess in panels E and F, M12.N
2). Lanes 1 represent control immunoprecipitates using irrelevant control antibody (Mac4
from irrelevant cell lines (A20 cells in panels E and F). Samples were analyzed by nonred
representing immunoprecipitating antibody, MHC class II a- and b-chains, MHC class
conditions, the bands migrated slightly faster than the nominal molecular weights for ea
for class I heavy chains; MW markers not shown).synthesis from experimental data are somewhat cumbersome,
and validation of model assumptions underlying this methodology
remains incomplete.
Here we wished to examine the utility of the SINEW approach,
combined with tryptic peptide analysis by liquid chromatography
(LC)–MS (Fig. 1B), for quantifying the synthesis of major histocom-
patibility complex (MHC) proteins. These membrane glycopro-
teins, abundant on immune cells, present antigens to T
lymphocytes of the adaptive immune system; their extensive ge-
netic polymorphism is important in acute allogeneic transplant
rejection and autoimmune disease susceptibility. The posttransla-
tional regulation of their fate and function is of great interest in
immunology and may be affected by polymorphism. Here we have
developed a peptide LC–MS method for measuring the fractional
synthesis of MHC protein allomorphs in cell culture by SINEW.1
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hance the versatility of this approach.Materials and methods
Cell lines
The human Epstein–Barr virus (EBV)-transformed B cell line,
Priess, was used to quantify synthesis of human leukocyte antigen
(HLA)-DR. Priess cells are homozygous at the HLA-DR locus,
expressing the DRB1*0401 allele along with the nearly monomor-
phic DRA*0101 gene product [18]. Monocyte-derived dendritic
cells were differentiated with GM-CSF (50 ng/ml) and IL4
(1000 U/ml) for 7 days after immunomagnetic bead isolation of
CD14+ monocytes from peripheral blood mononuclear cells.
LCL721 cells were used to quantify the synthesis of HLA-B*08
and B*51 MHC class I heavy chain gene products [19]. A20 murine
B lymphoma cells, derived from Balb/c mice (H-2d), or splenic B
cells from Balb/c mice were used as a source of murine H2-Ad (Aa-
dAbd heterodimer) MHC class II molecules [20]. Expression of MHC
molecules was veriﬁed by immunoﬂuorescent staining followed by
ﬂow cytometric analysis (data not shown).
For analysis of murine H2-Ag7 MHC class II molecules, M12.NOD
cells that were derived from the M12.C3 cell line by transfection
with a genomic construct coding for Ag7 b-chains (the Ada-chain,
identical to that in the g7 haplotype, is endogenously expressed)
were used. A 4.3-kbp BamHI–KpnI fragment, containing part of
the 50 ﬂanking sequences of the Abb promoter [21], was cloned
into pTCF. The entire Abg7 gene was subcloned from the cosmid
NOD-1–3 [22] isolated from a NOD liver cosmid library [23] as
an 11-kbp EcoRV fragment and subcloned into the ClaI site of
pTCF [24] following the addition of ClaI linkers to each end. The
50 end of the cloned Abg7 gene was extended by subcloning
the 10-kbp KpnI–ClaI Abg7 fragment into the KpnI–ClaI site of the
p 50-Abb-TCF described above. For transfection, the extended
Abg7–TCF plasmid was linearized with ClaI and added to M12.C3
cells as a calcium phosphate coprecipitate. Stable transfectants
were selected with 0.8 mg/ml G418, and the expression of H2-
Ag7 was conﬁrmed by staining with OX-6 (AbD Serotec, Oxford,
UK) and ﬂow cytometric analysis.
Antibodies
L243 is a murine IgG2a monoclonal antibody (mAb) speciﬁc for
the a-chain of assembled HLA-DR ab heterodimers [25]. W6/32 is a
murine IgG2a mAb speciﬁc for HLA-A, -B, and -C heavy chains
assembled with b2-microglobulin [26]. MKD6 is an IgG2a mAb spe-
ciﬁc for H2-Ad [27]. OX-6 is an IgG1 mAb speciﬁc for a polymorphic
determinant present on several H2-A alleles, including Ag7 [28].
Hybridoma supernatants were produced, and mAbs were isolated
on protein A or protein G afﬁnity columns (GE Biosciences), with
low-pH elution; puriﬁed antibodies were buffer exchanged, quan-
tiﬁed by absorbance at 280 nm, and stored at 20 C in phosphate-
buffered saline (PBS).
Cell culture and 2H2O labeling
Cells were maintained in suspension culture in a humidiﬁed
CO2 incubator (37 C) in RPMI 1640 medium (Gibco) supplemented
with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine (Sig-
ma), 1% penicillin/streptomycin, and 10 mM Hepes (Sigma). Expo-
nentially growing cell suspensions (typically 105–106 cells/ml)
were adjusted to approximately 5% 2H2O enrichment in medium
by the addition of 99% (mol/mol) 2H2O (Cambridge Isotope Labora-
tories), which was adjusted to 0.9% (w/v) NaCl, sterile ﬁltered, and(if needed) depleted of residual lipopolysaccharide on polymyxin B
columns (Pierce) according to the manufacturer’s instructions.
Cells were cultured in an incubator with 5% 2H2O in the humidiﬁer
dish, harvested at various times by centrifugation (350g, 10 min,
4 C), counted by hemocytometer with trypan blue exclusion,
washed in PBS, and stored at 80 C. For long-term culture
(>24 h), cells were counted and split daily with the addition of
medium containing approximately 5% 2H2O. Labeling experiments
were performed for at least ﬁve doublings to ensure nearly com-
plete (P97%) labeling. Medium and culture supernatants were
analyzed for 2H2O enrichment using isotope ratio mass spectrom-
etry (IRMS) after gravimetric dilution (MRC–HNR [Human Nutri-
tion Research], Widdowson Laboratories, Fulbourn, Cambridge,
UK) and equilibration with H2 gas [29].
MHC protein isolation
Immunoprecipitation was performed using modiﬁcations of
established protocols [30]. Unlabeled and 2H2O-labeled cell pellets
were lysed for 1 h at 4 C in 1% CHAPS (Sigma–Aldrich) or 1%
IGEPAL CA-630 (NP40) (Sigma) in 50 mM Tris (pH 8.0), 150 mM
NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), and protease
inhibitors (Roche Complete Protease Inhibitors used per manufac-
turer’s instructions) at a ratio of up to 108 cells/ml lysis buffer. Nu-
clei and debris were removed by centrifugation (10,000g in a
microcentrifuge, 30 min, 4 C). After preclearing with protein A or
protein G Sepharose (20 ll packed beads, Sigma–Aldrich), immu-
noprecipitation was performed using protein A or protein G Se-
pharose and 10–30 lg of the appropriate mAb (1 h to overnight,
4 C). Negative controls included the last preclearing step, irrele-
vant control antibody, and precipitation from a cell lacking the
protein of interest. Pellets were washed repeatedly in lysis buffer
with 0.1% detergent. One-dimensional sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) was performed
on 12% acrylamide gels under nonreducing conditions. Gels were
ﬁxed and stained with Coomassie blue or silver, and bands were
excised and stored at or below 20 C.
Sample preparation and peptide MS
SDS–PAGE gel pieces were thawed and transferred into 96-well
polymerase chain reaction (PCR) plates for automated sample
preparation in a Mass Prep Station (Waters). Brieﬂy, the gel bands
were destained, reduced (dithiothreitol [DTT]), alkylated (iodoa-
cetamide), and digested with trypsin overnight at 37 C. Thereafter,
20 ll of supernatant was pipetted into a sample vial and loaded
onto an autosampler for LC–tandem mass spectrometry (MS/MS)
analysis.
All LC–MS/MS and LC–MS experiments were performed using
an Eksigent NanoLC-1D Plus (Eksigent Technologies, Dublin, CA,
USA) high-performance liquid chromatography (HPLC) system
and an LTQ OrbiTrap mass spectrometer (ThermoFisher, Waltham,
MA, USA). Peptides were separated by reverse-phase chromatogra-
phy using a ﬂow rate of 300 nl/min and an LC Packings PepMap 100
C18 column (75 lm i.d.  150 mm, 3 lm particle size, Dionex, Sun-
nyvale, CA, USA). Peptides were loaded onto a precolumn (Dionex
Acclaim PepMap 100 C18, 5 lm particle size, 100 Å pore size,
300 lm i.d.  5 mm) from the autosampler with 0.1% formic acid
for 5 min at a ﬂow rate of 10 ll/min. The 10-port valve was then
switched to allow elution of peptides from the precolumn onto
the analytical column. Solvent A was 0.1% aqueous formic, acid
and solvent B was acetonitrile + 0.1% formic acid. The gradient em-
ployed was 5–50% B in 40 min. The LC eluate was sprayed into the
mass spectrometer by means of a New Objective nanospray source.
For MS/MS experiments, all m/z values of eluting ions were mea-
sured in the OrbiTrap mass analyzer set at a resolution of 7500.
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fragmented in the LTQ linear ion trap by collision-induced dissoci-
ation, and MS/MS spectra were acquired.
For peptide identiﬁcation, the data were processed using Bio-
works Browser (version 3.3.1 SP1, Thermo Fisher Scientiﬁc). MS/
MS data were converted to dta (text) ﬁles using the Sequest Batch
Search tool (within Bioworks). The data ﬁles were converted to a
single mgf ﬁle using an SSH script in the SSH Secure Shell Client
program (version 3.2.9, build 283, SSH Communications). These
combined ﬁles were then submitted to the Mascot search algo-
rithm (Matrix Science, London, UK) and searched against the
mouse or human NCBI database, as appropriate, using a ﬁxed mod-
iﬁcation of carbamidomethyl (for cysteines) and a variable modiﬁ-
cation of oxidation (for methionines).
The peptide identiﬁcations from the Mascot search were
matched to the M0 precursor peak in the chromatograms through
careful scrutiny of the MS/MS data contained within the Mascot
search result and the MS/MS spectra from the raw data. Once the
MS/MS data for individual unlabeled peptides had been matched,
the retention times of the peptides were established and this infor-
mation was used for the subsequent integrations (see below). For
quantiﬁcation of mass isotopomer distributions, selected ion mon-
itoring (SIM) experiments, in which limited m/z regions were
exclusively scanned for speciﬁc unlabeled or labeled ions, were
performed. Peak integration was performed using Xcalibur Qual-
Browser software (version 2.0, Thermo Fisher Scientiﬁc). Brieﬂy,
peaks were smoothed within QualBrowser (Boxcar, 7 points) to re-
move any spikes within the peaks before reconstructed ion chro-
matograms were generated for each mass isotopomer and the
areas under the peaks were measured. The reconstructed ion chro-
matograms posed no difﬁculties with respect to baseline drift or
variable peak shapes. Peak contamination was rarely seen and
was readily detectable by visual inspection of chromatograms
when present; the data shown were from uncontaminated chro-
matograms. Each peak was integrated across the same retention
time range to ensure that the areas of the peaks were consistent
for each mass isotopomer. Measured peak areas were copied into
Microsoft Excel spreadsheets for further analysis. The same peak
integration procedure was used for unlabeled, partially labeled,
and fully labeled peptides.
Calculations
Cell growth
Log-transformed cumulative cell counts (cell density per milli-
liter  volume, corrected for removal of cell samples or dilution
since the start of the experiment) were plotted as a function of
time. Doubling times were calculated from the slope of the best-ﬁt-
ting straight line according to the relationship:
t2 ¼ lnð2Þ=slope:Fractional protein synthesis
Standard nomenclature for mass isotopomer distribution analy-
sis (MIDA) calculations was used [31]. For each peptide, the mass
species corresponding to the monoisotopic molecular weight was
deﬁned as M0. This species comprises only the lowest atomic
weight isotopes of each element (i.e., all 12C/1H/16O/14N/32S).
Replacement of 1H by 2H, replacement of 12C by 13C, and so on at
any one position adds 1 Da, and the collection of these isotopomers
(isotopic isomer) is referred to as the M1 mass isotopomer. Any
combination of two of these substitutions, or replacement of 16O
by 18O, adds 2 Da, yielding M2 and so on.
Integrated LC peak intensities (designated I) measured across
the ﬁrst-dimension MS mass envelope of the peptide of interest
were converted to fractional molar abundances (designated A) bydividing the peak intensity of the mass isotopomer Mi
(i = 0, 1, 2, . . ., N) by the sum of the peak intensities of all (N + 1)
quantiﬁable mass isotopomers in the peptide mass envelope:
Ai ¼ Ii
XN
j¼0ðIjÞ
.
:
To measure the changes in mass isotopomer distributions over time
during a continuous 2H2O labeling experiment, the factional molar
abundance of each mass isotopomer at baseline was subtracted:
DAiðtÞ ¼ AiðtÞ  Aiðt ¼ 0Þ:
Replicate measurements of Ai and DAi were averaged, and standard
deviations were calculated.
Fractional protein synthesis (f) was calculated from the frac-
tional abundance of each mass isotopomer using the relationship
f ðtÞ ¼ DAiðtÞ=DA1i ; ð1Þ
where DA1i represents the maximal shift in fractional molar abun-
dance of the mass isotopomer from baseline, obtained empirically
from fully labeled samples. Estimates of f from different mass iso-
topomers within one peptide were averaged, and standard devia-
tions were calculated. Mass isotopomers with low values of DA1i
gave substantially noisier estimates of f (see Results) and were ex-
cluded from the analysis.
Mass isotopomer distribution analysis
MIDA uses combinatorial probability algorithms to calculate the
theoretical mass isotopomer distribution for any biomolecule both
at baseline (i.e., with all isotopes present at their natural abun-
dance) and after stable isotope labeling. MIDA algorithms have
been described exhaustively elsewhere [31] and were used in a
software implementation kindly provided by R.A. Neese and M.K.
Hellerstein.
The expected baseline mass isotopomer distributions, Ai,baseline,
were calculated from the elemental composition of each peptide,
which was determined from its sequence and corrected for added
protons (+1/charge acquired) and for carbamidomethylation of any
Cys residues present. In addition, the mass isotopomer distribu-
tions of fully labeled peptides were modeled. In the simplest mod-
el, used throughout the main text, the measured 2H2O enrichment
in medium was taken to represent the precursor pool enrichment
(designated p in the standard nomenclature used in MIDA calcula-
tions [31]). Mass isotopomer distributions were then calculated,
using MIDA software, for different numbers of labeling sites (des-
ignated n). Alternative models (see Supplementary material)
invoking uniform label dilution were calculated with MIDA soft-
ware using the indicated values of n and p. A nonuniform dilution
model was assembled in two steps. First, the baseline mass iso-
topomer distribution and the contribution of the fully labeled
hydrogens were modeled using MIDA software. Second, a spread-
sheet program was used to adjust for the contribution of the par-
tially labeled hydrogen atoms using Eq. (A3) of Ref. [31].
DAi values can be determined accurately only for those mass
isotopomers that can be quantiﬁed in both the unlabeled and la-
beled samples [31]. To allow comparison of MIDA calculations to
experiment, the predicted distributions were truncated to include
only the (N + 1) mass isotopomers that were experimentally quan-
tiﬁable and normalized to add up to 100%:
Ai;NORM ¼ Ai;MIDA
XN
j¼0 Aj;MIDA
 .
:
The truncation perturbs the linear relationship between measured
mass isotopomer abundances and f [31]; however, this bias is neg-
ligible when the measured mass isotopomer distributions account
for more than 90% of the total mass envelope [31], as was the case
here (data not shown). The goodness of ﬁt of the observed mass iso-
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square deviations (RMSDs) from the truncated, normalized MIDA
values:
RMSD ¼ p
XN
i¼0 Ai;obs  Ai;NORM
 2h .ðN þ 1Þ
i
;
where the summation was performed over all (N + 1) observed
mass isotopomers.
Results
Approach and peptide identiﬁcation
Initially, the synthesis of HLA-DR0401 molecules in Priess cells
was analyzed using the SINEW approach with peptide LC–MS anal-
ysis (Fig. 1B). Cells grew indistinguishably in the presence and ab-
sence of 4.5% 2H2O in medium (Fig. 1C); the 2H2O enrichment
remained constant throughout the culture period (Fig. 1D). HLA-
DR ab heterodimers were immunoprecipitated and visualized by
Coomassie blue staining after SDS–PAGE analysis (Fig. 1E). To iden-A
B
C
D
Fig. 2. Identiﬁcation of peptides suitable for 2H2O labeling studies. (A and B) Identiﬁcat
bands excised from SDS gels of L243 immunoprecipitates from Priess cell extracts were
Alignments of tryptic fragments to the sequence of their parent polypeptides are shown.
MS analysis of mass isotopomer distributions for the DRa peptide, FASFEAQGALANIAVDK
the M0 mass isotopomer of the doubly charged peptide. Integration of the principal LC p
quantify mass isotopomer distributions. (D) Mass spectrum for the LC peak of the intactify tryptic peptides suitable for kinetic analysis, unlabeled a- and
b-chain bands were excised, digested with trypsin, and analyzed by
LC–MS/MS for peptide sequencing. Matches to the DRa and
DR0401b protein sequences were identiﬁed using the Mascot
search algorithm and are shown in Fig. 2A and B. Peptides rich in
Ala and/or Gly, two of the amino acids that are nearly fully labeled
from 2H2O in mice [6], were identiﬁed in both chains (Table 1;
underlined in Fig. 2A and B). The quantiﬁcation of mass isotopomer
distributions in the relevant m/z range is shown for the DRa (51–
67) peptide in Fig. 2C and D. A single LC peak of the expected m/
z ratio was observed for the lowest (M0) mass isotopomer of the
peptide, comprising only the lowest atomic weight isotopes of each
element (Fig. 2C). Even in the absence of 2H2O labeling, a series of
mass isotopomers (M0–M4) was present at this retention time
(Fig. 2D) owing to the presence of stable isotopes in nature (e.g.,
1.09% 13C, 0.02% 2H). The individual mass peaks were separated
by 0.5 m/z units due to the z = 2 charge state of this peptide. The
identity of this peptide was conﬁrmed by comparing its MS/MS
spectrum, extracted from raw data, with the MS/MS spectrum
embedded in the Mascot search results (data not shown).ion of Ala-/Gly-containing HLA-DR4-derived tryptic peptides. DRa (A) and DRb (B)
reduced, carbamidomethylated, digested with trypsin, and analyzed by LC–MS/MS.
Peptides selected for analysis are shown in bold type and underlined. (C and D) LC–
. (C) LC chromatogram of a DRa digest, with SIM for m/z = 876.45, corresponding to
eak for this mass isotopomer, and for higher order mass isotopomers, was used to
t DRa peptide showing a single, well-resolved set of mass isotopomers.
Table 1
MHC protein-derived peptides used for analysis of 2H2O labeling.
Cell mAb Polypeptidea AAsb Sequencec m0/zd ze
Priess L243 DRa 51–67 FASFEAQGALANIAVDKf 876.46 2
DR0401b 73–80 AAVDTYCR f 478.22 2
LCL721g W6/32 B8 132–145 SWTAADTAAQITQR 760.28 2
i
B51 122–145 DYIALNEDLSSWTAADTAAQITQR 1327.48 2
i
317–338 GGSYSQAASSDSAQGSDVSLTA 1023.72 2
A20 MKD6 Aa 43–65 LPEFGQLILFEPQGGLQNIAAEKh 838.13 3
M12.NOD OX-6
A20 MKD6 Adb 73–80 AEVDTACR 461.21 2
M12.NOD OX-6 Ag7b 73–80 AELDTACR 468.22 2
a Mascot searches identiﬁed multiple peptides from the indicated HLA or H-2 polypeptides following speciﬁc immunoprecipitation using cells and antibodies as shown.
Peptides were selected on the basis of their Ala/Gly content and polymorphism.
b Amino acid sequence numbering refers to the mature protein.
c Amino acid sequences in single-letter code. Ala/Gly residues (whose side chain CAH bonds are known to be accessible to labeling from 2H2O) are underlined, and relevant
polymorphisms are in bold.
d Mass-to-charge ratios experimentally determined by LC–MS, where m0 mass represents the lowest mass isotopomer.
e Charge determined by the spacing of peaks in the MS mass envelope.
f The full set of HLA-DR0401-derived tryptic peptides is shown in Fig. 2A and B. No peptides were found to match the DRB4*0101-encoded DRw53 b-chain, which is
coexpressed in the DR4 haplotype and pairs with DRa; thus, DRw53 might not have been coisolated in substantial amounts.
g LCL721 is heterozygous in the MHC class I region; allele-speciﬁc HLA-B peptides were selected for analysis. Both polymorphisms within the peptide and adjacent
polymorphisms affecting tryptic cleavage can be exploited; the latter is illustrated here by the Ser131 polymorphism in the B51 (122–145) peptide, which destroys a tryptic
cleavage site present in B8.
h The a-chains of Ad and Ag7 are identical; the peptide shown was found in MKD6 immunoprecipitates from A20 cells (Ad) and in OX-6 immunoprecipitates from M12.NOD
(Ag7).
i The z = 3 triply charged peptide species were also present, albeit at lower abundance.
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The LC peak of each of the mass isotopomers of the unlabeled
DRa peptide was integrated, and its abundance was expressed as
a percentage of the total abundance of the M0 to M4 mass isotop-
omers (Fig. 3A). Standard deviations (SDs) of six replicate injec-
tions ranged from 0.08% to 0.43% for the different mass
isotopomers, indicating high analytical precision. MIDA allows
baseline fractional molar abundances to be predicted from the ele-
mental composition of the peptide; the combinatorial probability
algorithms used in MIDA have been reviewed [31]. The data agreed
with MIDA predictions (Fig. 3A) to within experimental error; the
RMSD between MIDA prediction and experiment was 0.15% for
the average of the replicates and ranged from 0.25% to 0.38% for
the six individual determinations. The measured distributions
were also reproducible between experiments (see Fig. S1a in Sup-
plementary material). When input cell numbers were varied over
two orders of magnitude, the abundance of the DR molecules
recovered, and of the DRa peptide after LC–MS analysis, varied
accordingly (Fig. S1b). The shape of the mass isotopomer distribu-
tions was maintained at lower analyte abundance, albeit with lar-
ger deviations from MIDA predictions (Fig. S1b). Thus, the mass
isotopomer distributions of tryptic peptides are measured accu-
rately and precisely by LC–MS, with only modest loss of precision
at low analyte abundance; moreover, RMSD values represent a
useful estimate of measurement accuracy.
Next, the shifts in peptide mass isotopomer distributions were
evaluated after growing Priess cells in 2H2O for approximately ﬁve
doublings (Fig. 1C and D), so that approximately 97% of the cells,
and thus at least 97% of protein, would incorporate 2H at 4.5%
2H2O enrichment. 2H2O labeling caused a visible shift in the mass
isotopomer distribution of the tryptic DRa (51–67) peptide
(Fig. 3B and C). The SD of the fractional molar abundances of the
M0 to M4 mass isotopomers after ﬁve replicate injections ranged
from 0.10% to 0.18% (Fig. 3C). By comparison, the changes in frac-
tional mass isotopomer abundance on labeling were substantial,
ranging from 22.5% for M0 to +12.3% for M3 (Fig. 3D).MIDA algorithms were used to model the effects of 2H2O label-
ing on the mass isotopomer distributions [31]. The shape of the la-
beled distributions depends on the number of labeling sites (n) and
the isotope enrichment in the precursor pool (p). During 2H2O
labeling, 2H atoms enter the peptide individually at an unknown
number of labeling sites within the NEAAs present; the precur-
sor/product relationship depends on the amino acid composition
of the peptide. The simplest model involves a ﬁxed number (n) of
biosynthetic labeling sites, at each of which 2H is biosynthetically
incorporated from 2H2O without label dilution from competing
sources (i.e., at p = 4.5% 2H enrichment in this experiment). This
model gave excellent agreement with the labeled mass isotopomer
distributions when the value of n was adjusted for optimal ﬁt to
the data (n = 22–23 in several independent determinations,
RMSD = 0.2–0.3%) (Fig. 3C and D, and Table 2). The optimal value
of nwas well matched to the total number of CAH bonds [22] nom-
inally attributable to the side chains of Ala (n = 4/residue) and Gly
(n = 2). Thus, 2H incorporation into the DRa peptide under these
culture conditions is almost entirely accounted for by labeling of
Ala and Gly, although contributions from other amino acids, and la-
bel dilution in Ala and Gly, were not ruled out by our data.
The DR0401b (73–80) peptide was also analyzed. Its unlabeled
mass isotopomer distribution was reproducible, conforming to
MIDA predictions (Figs. 3E and S1c). SDs ranged from 0.09% to
0.43% for different mass isotopomers; RMSD was 0.43% for the
average of ﬁve replicates, and RMSDs for individual determinations
ranged between 0.19% and 0.71%. For the labeled samples, the best
model ﬁt to the data was obtained assuming n = 8 or 9 labeling
sites labeled at p = 4.5% 2H enrichment (Fig. 3F–H and Table 2). This
labeling pattern is well matched to the eight labeling sites attribut-
able to the two Ala residues in this peptide.
We wished to examine whether the MHC-derived peptides also
incorporate the 2H label at exchangeable sites, such as solvent-ex-
posed OAH and NAH bonds [32], which would confound the anal-
ysis of biosynthetic label incorporation at nonexchangeable CAH
bonds. Thus, unlabeled Priess cells were lysed in 2H2O-enriched ly-
sis buffer, immunoprecipitated, and washed in unenriched buffer.
Fig. 3. Mass isotopomer distributions of HLA-DR4-derived tryptic peptides. (A–D) Analysis of DRa (51–67) peptide. (A) MIDA model and experimental quantiﬁcation
(means ± SDs of N = 6 replicate injections) of mass isotopomer distributions of the unlabeled DRa peptide. (B) Mass spectrum of the DRa peptide obtained before and after
6 days of culturing Priess cells in 4.5% 2H2O. (C) MIDA model and experimental quantiﬁcation (means ± SDs, N = 5) of mass isotopomer distributions after 2H2O labeling. The
model assumes that n = 22 labeling sites are accessible to label without dilution of the precursor pool enrichment (p) relative to the 2H2O enrichment in medium; the value of
n was adjusted for optimal ﬁt to the data. (D) The difference between the mass isotopomer distributions of the fully labeled and unlabeled DRa peptide is shown. The inset
shows the RMSD of the experimental data from a series of models in which p was kept at 4.5% and n was varied. The lowest RMSD value was obtained at n = 22. (E–H) The
same analysis was applied to the DR0401b (73–80) peptide: (E) unlabeled mass isotopomer distributions (means ± SDs, N = 5 replicates); (F) mass spectra of unlabeled versus
extensively labeled peptide; (G) mass isotopomer distributions of labeled peptide (means ± SDs of N = 5 replicate analyses, RMSD = 0.45% vs. model with n = 8 labeling sites
and p = 4.5%); (H) difference analysis and dependence of model ﬁt on n (inset).
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topomer distributions due to 2H2O exposure post lysis (Fig. S1d).
Thus, label retention at exchangeable sites does not confound mea-
surements of protein synthesis.
The analysis was extended to other MHC proteins. Human
HLA-A, -B, and -C class I molecules were isolated from EBV-transformed B cells, and murine H2-Ag7 class II molecules were iso-
lated from M12.NOD transfectants (Fig. 1F and G). H2-Ad mole-
cules, isolated from A20 B lymphoma cells, were obtained in
lower abundance and detected by silver staining (not shown).
LC–MS/MS analyses identiﬁed suitable peptides within H2-Ad
and H2-Ag7 a- and b-chains (Table 1; note that both alleles share
Table 2
Summary of MIDA calculations.
Peptidea n (Ala+Gly)b Experiment Source Labeling (days) 2H2O (p) c (%) n (experimental)d RMSD (%)e
DRa (51–67) 22 1 Priess 6 4.5 22 0.33
2 Priess 6f 4.5 22 0.33
8 4.5 23 0.20
3 DC Nil – – 2.02
3 4.9 22 0.75
DR0401b(73–80) 8 1 Priess 6 4.5 8 0.54
2 Priess 6f 4.5 8 0.45
8 4.5 9 0.53
B8 (132–145)g 16 1 LCL721 Nil – – 0.27
7 4.5 15 0.32
B51 (122–145)g 20 LCL721 Nil – – 0.67
7 4.5 28 0.23
B51 (317–338) 22 1 LCL721 Nil – – 0.58
7 4.5 24 0.59
Aa (43–65) 14 1 A20 Nil – – 0.33
6 4.8 22 0.57
2 A20 Nil – – 0.26
5 5.6 24 0.87
3 M12.NOD Nil – – 0.22
5 5.0 26 0.17
4 M12.NOD Nil – – 0.26
5 5.6 24 0.87
5 Balb/c spl Nil – – 0.33
Adb (73-80) 8 1 A20 Nil – – 0.27
5 4.8 9 0.57
2 Balb/c spl Nil – – 0.27
Ag7b (73–80) 8 1 M12.NOD Nil – – 1.73
6 5.0 11 0.29
a See Table 1 for sequences and masses.
b Number of CAH bonds in Ala and Gly residues of the peptide.
c 2H2O enrichment in medium (atom % excess over natural abundance) measured by IRMS.
d MIDA calculations were performed using medium 2H2O enrichment to represent p and varying the number of labeling sites (n); the value of n that gave the best ﬁt to the
data is given.
e RMSD values indicate the goodness of ﬁt of the optimized MIDA model (per noted) to the data.
f Average of ﬁve replicate analyses shown in Fig. 3. Statistics for the corresponding unlabeled DR mass isotopomer distributions are given in the text, Fig. 3, and Fig. S1 in
the Supplementary material.
g Data for the z = 2 charge state are given. Triply charged (z = 3) species gave similar best-ﬁt values of n (14 for B8 peptide, 27 for B51) but gave greater RMSD values related
to their lower abundance.
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derived peptides was identiﬁed in HLA class I immunoprecipitates
from LCL721 cells, allowing the identiﬁcation of Ala-/Gly-rich pep-
tides that were speciﬁc for either allele (Table 1). The unlabeled
mass isotopomer distributions of all peptides conformed to MIDA
predictions (Table 2 and Fig. S2 in Supplementary material, left
panels). The mass isotopomer distributions after extensive 2H2O
labeling were substantially shifted and were modeled well by
assuming a ﬁxed number of labeling sites (n) that incorporate 2H
at the measured body water enrichment (Table 2 and Fig. S2, right
panels). For several peptides, the best-ﬁt values of n were close to
the number of CAH bonds attributable to Ala and Gly. For the B51
(122–145) and Aa (43–65) peptides, however, only 20 of 28 and 14
of approximately 24 labeling sites, respectively, were explained by
Ala and Gly, implying contributions from other amino acids to
labeling (Table 2).Quantiﬁcation of fractional protein synthesis
In metabolic labeling experiments, the enrichment in the iso-
tope-labeled precursor pool is generally kept constant, so that
newly synthesized molecules incorporate the label to the same ex-
tent regardless of when they are synthesized. In the SINEW ap-
proach, however, the NEAA tRNAs used for protein synthesis are
labeled indirectly from 2H2O. At early time points, label equilibra-
tion might be incomplete, so that p or n might increase over time.
This would confound the estimation of fractional protein synthesis
(f) from 2H2O labeling data. Previous work has shown that CAHbonds of Ala and Gly precursors are rapidly labeled from 2H2O
[5–7,10], but considerable label dilution has been noted in Pro
[15] and data for 2H2O labeling of other NEAAs in cell culture are
unavailable. Thus, the possibility of delayed label entry was a con-
cern, particularly for peptides whose label incorporation patterns
were only partially accounted for by their Ala and Gly content.
Therefore, we considered the behavior of mass isotopomer dis-
tributions during a labeling time course assuming that there is no
change in p or n. If this assumption is correct, old molecules, which
retain the baseline mass isotopomer distribution, will gradually be
replaced (during protein turnover) or diluted (due to cell growth)
with new molecules, all of which possess a mass isotopomer distri-
bution identical to that of fully labeled molecules. Thus, the mass
isotopomer distribution, Ai(t), of a partially turned-over protein
pool (i.e., the fractional molar abundance, A, of mass isotopomer i
at time t) is the weighted average of the unlabeled [Ai(0)] and fully
labeled (A1i ) mass isotopomer distributions; the weighting factor,
f(t), represents fractional protein synthesis:
AiðtÞ ¼ ½1 f ðtÞ  Aið0Þ þ f ðtÞ  A1i :
Thus, fractional protein synthesis, f(t), can be calculated as
f ðtÞ ¼ AiðtÞ  Aið0Þ½ = A1i  Aið0Þ
  ¼ DAiðtÞ=DA1i : ð1Þ
Therefore, if there is no change in precursor/product relationships
during the experiment, each mass isotopomer will change from
its baseline to its fully labeled value at the same rate, characteristic
of the rate of fractional protein synthesis, and will provide an inde-
pendent estimate of f. In contrast, if the label equilibrates poorly
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tributions of molecules synthesized early on; therefore, analysis of
different mass isotopomers using Eq. (1) will yield systematically
different estimates of f (see Fig. S3 in Supplementary material).
Accordingly, we examined whether the analysis of different
mass isotopomers yields convergent estimates of f according to
Eq. (1). Fig. 4A shows the mass isotopomer distributions of the
H2-Aa (43–65) peptide from Ag7 molecules isolated after varying
times of 2H2O labeling of M12.NOD cells. All intermediate distribu-
tions intersected at a common ‘‘iso-abundant” point near M2 (ar-
row). This observation was consistent with the intermediate
distributions representing binary mixtures of unlabeled and fully
labeled molecules (analogous to the isosbestic point found inC
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within any one peptide. This result was consistent with the
hypothesis that the precursor/product relationships for peptide
labeling from 2H2O are effectively independent of time, justifying
the use of Eq. (1) to calculate f from 2H2O-labeled peptide mass iso-
topomer distributions. The estimates of f were validated by com-
parison between different charge states of the same peptide,
different peptides of the same polypeptide, or a peptide from a
partner chain (Figs. 4D–H). The estimates were less precise for
H2-Ad molecules; this was attributed to the low expression of
these molecules in A20 cells, resulting in low MS abundance. The
fractional synthesis rates measured in these experiments corre-
sponded to half-lives on the order of approximately 1 day
(Fig. 4D–H), with different contributions from cell growth and from
replacement of turned-over proteins to fractional synthesis,
depending on the MHC molecule and its cellular background (A.
De Riva et al., manuscript in preparation).Studies in primary APCs
This analytical approach also was feasible for primary antigen-
presenting cells (APCs) cultured in vitro or obtained ex vivo. Unla-
beled and fully labeled mass isotopomer distributions of the DRa
peptide, obtained from immature human monocyte-derived den-
dritic cells, and the baseline mass isotopomer distributions of the
Ad a and b peptides, obtained from Balb/c splenic B cells, closely
conformed to MIDA predictions (Table 2). Thus, the SINEW ap-
proach will be applicable to primary APCs.Discussion
Here we have used peptide LC–MS, in conjunction with the SI-
NEW approach (Fig. 1B), to quantify the fractional synthesis of var-
ious MHC proteins. In the process of validating this method, we
tested key underlying assumptions, explored the generality and
versatility of the method, and greatly simpliﬁed the algorithms
used to calculate fractional protein synthesis from experimental
data. Importantly, the method is capable of distinguishing turnover
rates of closely related MHC protein allotypes present in the same
cell. Collectively, these improvements substantially broaden the
utility of the SINEW approach.
Speciﬁcity is achieved at several steps in the procedure. MHC
proteins of interest are enriched by immunoprecipitation followed
by SDS–PAGE. However, contamination with the immunoprecipi-
tating antibody, noncovalently associated or copuriﬁed proteins,
and keratin remains detectable by LC–MS/MS (data not shown).
Nonetheless, suitable peptides speciﬁc for the proteins of interest
are found, and uncontaminated mass envelopes are obtained, as
indicated by the close match to MIDA predictions. Unique peptide
masses and retention times allow discrimination between peptides
derived from MHC class I and class II allelic variants even when
several MHC molecules are present. In Fig. 4G and H, we analyzed
two alleles encoded at the HLA-B class I MHC locus, but HLA-A and
-C were coisolated using the W6/32 antibody. Preliminary studies
in another lymphoblastoid cell line (not shown) suggest that the
entire class I haplotype will be resolvable provided that the HLA
type is available. Thus, peptide LC–MS greatly improves analytical
speciﬁcity in the SINEW approach compared with the analysis of
2H incorporation into protein-derived NEAAs after total hydrolysis.
The tolerance of our method to complexity in the protein samples
suggests that our approach may have applications in kinetic
proteomics.
Measured mass isotopomer abundances must be both precise
and accurate to enable determination of f by stable isotope labeling
[31]. OrbiTrap MS analysis satisﬁes these criteria, comparing favor-ably with the performance of other MSmodalities in previous stud-
ies [16,17]; the data are analytically precise (SDs = 0.2–0.3% for
high-abundance samples) and accurate (abundance independent
and consistent with MIDA predictions). Accuracy diminishes some-
what at lower analyte abundance; thus, the best results require
minimization of sample losses throughout the procedure. None-
theless, analysis of MHC molecules isolated from as few as 105
EBV-B cells was possible, comparing favorably with 35S radiolabel-
ing. Substantial shifts in abundance are observed after complete
2H2O labeling on the order of 20% for M0 and +10% for other mass
isotopomers in each peptide. Thus, estimation of f to within a few
percentage points is possible, provided that mass isotopomers that
show the greatest fractional abundance shifts during labeling are se-
lected for analysis. Allowing for the contribution of cell growth to
fractional synthesis measured by our approach, our measurements
(Fig. 4 and data not shown) are compatible with the MHC protein
half-lives measured previously by radiolabeling in immortalized B
cell lines [30,33] and monocyte-derived dendritic cells [34].
The success of this approach relies on the identiﬁcation of pep-
tides that incorporate sufﬁcient label from 2H2O. Prospective iden-
tiﬁcation of such peptides from their amino acid sequence remains
a complex challenge because the efﬁciency with which each amino
acid incorporates the 2H label depends on the activity of complex
biosynthetic pathways and on the abundance of unlabeled amino
acids present in culture medium, and this may dilute any label
incorporated via endogenous amino acid synthesis to an unknown
extent. Previous work showed that CAH bonds in Ala and Gly are
nearly fully equilibrated with 2H from 2H2O in vivo in rodents, con-
tributing n = 4 and n = 2 labeling sites each, respectively, to pep-
tides containing these amino acids [6,11]. We reasoned that
these amino acids should be well labeled in vitro as well based
on previous studies showing good labeling of protein-derived Ala
in cell culture [13] and based on the lack of Ala and a modest
amount of Gly present in RPMI medium. Accordingly, we preselect-
ed peptides on the basis of Ala/Gly content. In several of the pep-
tides examined, Ala or Gly labeling explained most or all of the
labeling sites inferred from MIDA calculations, but this did not rule
out contributions from other amino acids that would have been ex-
pected from previous work [11]. Indeed, in other peptides, such as
the Aa peptide, a substantial proportion of labeling sites must have
arisen from labeling of other NEAAs. Similarly, in previous studies
performed in vivo, some well-labeled peptides that were not rich
in Ala/Gly were found [16,17]. A preliminary analysis of 21 pep-
tides (including data in Table 1 and unpublished work) reinforces
our impression that numerous amino acids contribute to labeling
in our system (data not shown).
Counting of Ala and Gly residues, therefore, will often underpre-
dict the extent of labeling and will miss some well-labeled pep-
tides. However, most proteins contain some Ala-/Gly-rich
peptides, and other well-labeled peptides may be identiﬁed empir-
ically if needed, so this does not appear to be a serious limitation in
practice. Moreover, we observed no peptides in which the apparent
number of labeling sites (n) was markedly less than that attribut-
able to Ala/Gly, suggesting that the counting of Ala and Gly pro-
vides a useful lower bound on the number of labeling sites that
may be expected. Importantly, this lower bound is likely to apply
in vivo in rodents, where Ala and Gly are known to be well labeled.
A more complete and accurate set of rules for predicting highly la-
beled peptides from amino acid sequence will require reﬁnement
of predictive algorithms and validation in larger data sets.
Given the potential complexity of precursor/product relation-
ships for 2H2O labeling of NEAAs, it is interesting that a simple
MIDAmodel, in which a ﬁxed number of labeling sites are assumed
to be labeled at the 2H enrichment in medium water, accounts
quantitatively for the observed labeling patterns, as was also found
previously for selected rodent serum proteins [17]. However, more
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NEAA precursor pools, ﬁt the data equally well (see Fig. S4 in Sup-
plementary material). Thus, neither the experimental data nor the
MIDA models are sensitive to the biochemical details that govern
labeling of peptides from 2H2O. Indeed, the calculation of fractional
protein synthesis, using Eq. (1), makes no assumptions about the
precursor/product relationships, as captured in MIDA calculations
(values of n and p), nor does it assume any knowledge as to the
metabolic source of the label (e.g., whether 2H is introduced via
Ala, Gly, or any other amino acid). For this reason, the approach
outlined here permits calculation of fractional protein synthesis
despite our incomplete understanding of the biochemical details
underlying the observed labeling patterns.
The use of Eq. (1) to calculate f represents an application of the
rise-to-plateau approach [35]. This is a rigorous approach for
determining fractional synthesis that is feasible when a stable iso-
tope label can be administered continuously for extended periods,
allowing empirical deﬁnition of plateau labeling. Labeling to pla-
teau is possible in the SINEW approach both in cell culture and
in living animals [6]. The only additional assumption inherent in
Eq. (1) is that the precursor/product relationship remains constant
on the time scale of the experiment, which was consistent with our
empirical results. It should be noted that the assumption of a con-
stant precursor/product relationship also underlies the MIDA-type
algorithms used in previous work to calculate f [16,17], although
this assumption was not previously tested experimentally. More-
over, our model calculations (see Figs. S3 and S5 in Supplementary
material) show that minor violations of these assumptions (small
ﬂuctuations in values of n or p or delayed label equilibration from
2H2O into NEAA precursor pools) have only minimal impact on
estimates of f. This argues for the robustness of our approach.
Operationally, Eq. (1) greatly simpliﬁes calculation of f and of the
associated experimental error.
Our validation studies focused on cultured, immortalized B cell
lines, but the method also is applicable in human monocyte-de-
rived dendritic cells and murine splenic B cells. By extrapolation
from our results, in vivo studies in rodents appear to be feasible,
consistent with previous work on abundant serum proteins
[16,17]. 2H2O enrichments of 5%, used in the cell culture studies
presented here, are routinely used for extended continuous label-
ing of rodents in vivo; 2H2O label equilibration with Ala and Gly,
which are present in the peptides we selected, is rapid and nearly
complete in vivo [5–7,10]. Moreover, overall label incorporation in
cell culture appears to be less complete than would be expected
from the data of Commerford and coworkers [11] in mice (based
on data in Table 1 and unpublished observations). This is likely
due to competition with unlabeled exogenous amino acids in med-
ium and serum. These considerations suggest that the values of n
in vivo will not be the same as in cell culture but rather will gen-
erally be higher. This would pose no difﬁculty in calculating f from
shifts in mass isotopomer distributions in vivo and may even make
in vivo analyses more robust. However, the precursor/product rela-
tionships (best-ﬁt values of n for the peptides of interest) would
need to be redetermined in vivo because they cannot be simply
extrapolated from results obtained in cell culture.
Further work will be required to examine whether the approach
can be extended to human in vivo studies because lower 2H2O
enrichments (1–2% in plasma) are routinely attained in humans
andadditional sources of label dilutionmaybepresent [6]. However,
MIDA calculations predict that at 1–2% 2H2O enrichment, the shifts
inmass isotopomer abundance for fully labeled HLA-B and -DR pep-
tides would range from 4% to 13% in M0 and from +2% to +8% in
the best higher order mass isotopomers. This may be sufﬁcient to
estimate f.
The approach can readily be extended to other proteins. A pow-
erful feature of 2H2O labeling is the ability to combine studies ofprotein dynamics with analyses of lipid synthesis [36] and cell pro-
liferation (measured as DNA synthesis, reviewed in Ref. [8]) using
the same biosynthetic label. The use of peptide LC–MS in SINEW
experiments promises to become a convenient and powerful tool
for studies of protein synthesis and turnover in a variety of biom-
edically relevant in vitro settings and ultimately in kinetic proteo-
mics. The ability to distinguish biosynthetic rates of protein
allomorphs, in particular, will be an invaluable tool for dissecting
the role of protein dynamics in genotype/phenotype relationships.
Extension to in vivo settings appears to be feasible and would open
up a wide range of potential applications in which synthesis and
turnover of long-lived proteins may be measured in healthy hu-
man populations and animal models and their perturbation by dis-
eases and therapeutic interventions may be quantiﬁed.
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